Company news
Halberd Corp. (OTC:HALB) news
Halberd Corp. news releases on 6ix. Latest, Feb 1, 2021: Halberd Corporation's CEO Interviewed on The Stock Day Podcast and on MoneyTV
Press releases — page 4
Halberd Corporation's CEO Interviewed on The Stock Day Podcast and on MoneyTV
January 31, 2021
This Week on MoneyTV with Donald Baillargeon, 1/29
January 28, 2021
Halberd Corporation’s Research Breakthrough - Qualitative & Quantitative Measurement of Covid-19 Antigens and/or Antibodies
January 24, 2021
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19)
January 13, 2021
Halberd Corporation’s Covid-19 Efforts Recognized in Wall Street PR News Article
January 11, 2021
Halberd Corporation 2020 Year End CEO Letter
January 3, 2021
Halberd Corporation Produces a Second Monoclonal Antibody Against Covid-19 Spike Protein
December 22, 2020
Halberd Corporation Pursues Extracorporeal Radio Frequency Treatment Against Covid-19
December 16, 2020
Halberd Corp. Research Yields Potent SARS-CoV-2 Antibody
December 13, 2020
Halberd Corp. Research Yields Promising SARS-CoV-2 Antibody in Laboratory Testing
December 6, 2020
Halberd Corporation's Covid-19 Technology Recognized by Momentum Observer
December 1, 2020
Halberd Corporation Advisory Board Reorganization Announced
November 30, 2020
Halberd Corp. CEO Interviewed on Money TV; Discusses 2020 Accomplishments and Plans
November 24, 2020
Halberd Corporation Files for Patent Protection on Covid-19 Extracorporeal Treatment Variation
November 18, 2020
Halberd Corp. CEO Interviewed on Money TV; Discusses New Fluorescent Covid-19 Antibody
November 15, 2020
This Week on MoneyTV with Donald Baillargeon, 11/13
November 12, 2020
Halberd Corporation Reveals Patent-Pending Fluorescent Antibody's Wide Role in Covid-19 Detection & Treatment
November 11, 2020